InvestorsHub Logo
Followers 6
Posts 484
Boards Moderated 0
Alias Born 04/14/2013

Re: None

Friday, 08/15/2014 5:37:00 PM

Friday, August 15, 2014 5:37:00 PM

Post# of 260
Wow, Look at This: Not Good at all, "deteriorating net income"


NEW YORK (TheStreet) -- Ironwood Pharmaceuticals (IRWD_) was falling -8.2% to $13.63 Tuesday after missing analysts estimates for earnings and revenue for the second quarter.

The company reported a loss of -38 cents a share for the second quarter, missing the Capital IQ Consensus Estimate of -36 cents a share by 2 cents. Revenue fell -29.2$ year-over-year to $6.84 million for the quarter. Analysts expected revenue of $15.75 million in the quarter.


The Street Ratings team rates IRONWOOD PHARMACEUTICALS INC as a Sell with a ratings score of D. The Street Ratings Team has this to say about their recommendation:

"We rate IRONWOOD PHARMACEUTICALS INC (IRWD) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The area that we feel has been the company's primary weakness has been its deteriorating net income."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IRWD News